InvestorsHub Logo
Followers 4
Posts 301
Boards Moderated 0
Alias Born 08/27/2023

Re: None

Friday, 04/19/2024 4:58:53 AM

Friday, April 19, 2024 4:58:53 AM

Post# of 426948
“In April 2024, Amarin (NASDAQ: AMRN) Corporation plc showcased two data presentations at ACC.24 which describe the impacts of VASCEPA ®/VAZKEPA ® on decreasing adverse cardiovascular events in patients with reduced lipoprotein level or baseline high and decreases the risks of cardiovascular diseases.”
https://www.precedenceresearch.com/lipid-lowering-drugs-market
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News